摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Methyl-4-(methylamino)-6-methylsulfanylhexan-3-one

中文名称
——
中文别名
——
英文名称
2-Methyl-4-(methylamino)-6-methylsulfanylhexan-3-one
英文别名
2-methyl-4-(methylamino)-6-methylsulfanylhexan-3-one
2-Methyl-4-(methylamino)-6-methylsulfanylhexan-3-one化学式
CAS
——
化学式
C9H19NOS
mdl
——
分子量
189.32
InChiKey
KZJXUFFIDZUEIK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    12
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    54.4
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Compounds useful in the treatment and/or care of the skin, hair, nails, and/or mucous membranes
    申请人:LUBRIZOL ADVANCED MATERIALS, INC.
    公开号:US10799442B2
    公开(公告)日:2020-10-13
    Compounds of general formula (I): R1-Wm-Xn-AA1-AA2-AA3-AA4-AA5-AA6-Yp-Zq-R2 (I) their stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, cosmetic and/or pharmaceutical compositions which contain them and their use in medicine, and in processes of treatment and/or care of the skin, hair and/or mucous membranes, in particular in the aging and photoaging of the skin.
    通式 (I) 的化合物:R1-Wm-Xn-AA1-AA2-AA3-AA4-AA5-AA6-Yp-Zq-R2(I)的立体异构体、它们的混合物和/或它们的化妆品或药剂上可接受的盐、含有它们的化妆品和/或药剂组合物,以及它们在医学、皮肤、头发和/或粘膜的治疗和/或护理过程中的用途,尤其是在皮肤老化和光老化方面的用途。
  • [EN] CYCLIC PEPTIDYL INHIBITORS OF CAL-PDZ BINDING DOMAIN<br/>[FR] INHIBITEURS PEPTIDYLIQUES CYCLIQUES DU DOMAINE DE LIAISON CAL-PDZ
    申请人:OHIO STATE INNOVATION FOUNDATION
    公开号:WO2019148195A2
    公开(公告)日:2019-08-01
    Described herein, in various embodiments, are peptides comprising: (i) a cyclic cell-penetrating peptide sequence (cCPP) and (ii) a CAL-PDZ binding sequence, which is conjugated, directly or indirectly, to an N-terminus of an amino acid in the cCPP, to a C-terminus of an amino acid on the cCPP, or on a side chain of an amino acid in the cCPP. In other embodiments, the peptides further comprise a physiologically cleavable group, wherein after entering the cell, the physiologically cleavable group is reduced, thereby providing a linear peptide. Without being bound by theory, the inventors discovered that the amino acid sequence in the cCPP, which facilities cytosolic delivery of the CAL-PDZ binding sequence also, surprisingly and unexpectedly, synergistically improves binding of CAL-PDZ binding sequence to the CAL-PDZ binding domain. Additionally, the cCPP sequence may also improve selectivity of the CAL-PDZ binding sequence for the CAL-PDZ domain relative to other PDZ binding domains.
查看更多